Wave Life Sciences
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $83,748 | $-7,676 | $19,692 | $12,538 |
Gross Profit | 83,748 | -7,676 | -20,701 | 10,361 |
EBITDA | 25,123 | -61,757 | -32,825 | -32,281 |
EBIT | 22,967 | -63,915 | -34,997 | -34,458 |
Net Income | 29,253 | -61,780 | -32,923 | -31,558 |
Net Change In Cash | 83,748 | -7,676 | 19,692 | 12,538 |
Free Cash Flow | -43,734 | -46,861 | -27,520 | -33,849 |
Cash | 302,078 | 310,948 | 153,958 | 180,922 |
Basic Shares | 172,290 | 132,563 | 129,527 | 129,271 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $108,302 | $113,305 | $3,649 | $40,964 |
Gross Profit | 108,302 | 104,099 | 3,649 | -80,911 |
EBITDA | -110,403 | -58,790 | -152,606 | -117,181 |
EBIT | -67,996 | -162,720 | -127,016 | |
Net Income | -97,008 | -57,513 | -161,823 | -122,245 |
Net Change In Cash | 108,302 | 113,305 | 3,649 | 40,964 |
Cost of Revenue | -61,848 | -33,725 | ||
Free Cash Flow | -151,026 | -20,546 | -129,142 | -89,553 |
Cash | 302,078 | 200,351 | 88,497 | 150,564 |
Basic Shares | 138,277 | 106,097 | 78,855 | 51,825 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $0.27 |
2024-09-30 | -$0.46 |
2024-06-30 | -$0.25 |
2024-03-31 | -$0.24 |
